Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-08

FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for escitalopram oral solution, adding an approved oral solution formulation for the antidepressant SSRI from Chartwell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram oral solution (escitalopram oral solution)

Snippet

SUPPL AP for ESCITALOPRAM ORAL SOLUTION (ESCITALOPRAM ORAL)